Insights › Medicine & pharma › November 15, 2026
Medicine & pharma · Official intelligence

Once-Weekly Ribupatide for Weight Loss in Adults in China With Overweight or Obesity: The GEMINI-1 Randomized Clinical Trial

INT JAMA Published:

A randomized clinical trial published in JAMA evaluated the efficacy of once-weekly ribupatide for weight loss in Chinese adults with overweight or obesity. This study provides new evidence on the effectiveness of this treatment regimen for managing obesity in this population.

Original source
Read the source — pubmed.ncbi.nlm.nih.gov ↗

We link to the original publisher. The summary above is a short guide; read the original for the full details.

More in Medicine & pharma

See everything in Medicine & pharma →

Look into this further

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it all — start from $3No app-store installation. Cancel any time.